Skip to content
REGN Regeneron Pharmaceuticals Inc NASDAQ
900.16 USD 0.37% +3.34
OPEN 904.54
DAY RANGE 908.67 - 897.45
52 WEEK RANGE 998.33 - 684.81
Interactive Brokers Logotype

Buy REGN stocks now with Interactive Brokers – the most advanced investment platform


Valuations metrics

Market capitalization 98.8B
Enterprise value 88.7B
Trailing pe 25.903885
Forward pe 18.938776
Peg ratio 18.938776
Price to sales ttm 7.532351
Price to book mrq 3.7124286
Enterprise to revenue 6.76
Enterprise to ebitda 19.053


Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.30141002
Operating margin 0.29202
Return on assets ttm 0.08494
Return on equity ttm 0.16258
Income statement
Revenue ttm 13.1B
Revenue per share ttm 122.935
Quarterly revenue growth 0.006
Gross profit ttm 11.3B
Ebitda 5.1B
Net income to common ttm 4B
Diluted eps ttm 34.75
Quarterly earnings growth yoy -0.031
Balance sheet
Total cash mrq 10.8B
Total cash per share mrq 100.918
Total debt mrq 2.8B
Total debt to equity mrq 10.744
Current ratio mrq 5.69
Book value per share mrq 242.472
Cash flow
Operating cash flow ttm 4.6B
Levered free cash flow ttm 2.8B

Stock statistics

Shares outstanding 107.9M
Float shares 102.8M
Avg 10 volume 502.8K
Avg 90 volume 451.5K
Shares short 1.4M
Short ratio 3.19
Short percent of shares outstanding 0.0154
Percent held by insiders 0.02582
Percent held by institutions 0.89287

Stock price summary

Fifty two week low 684.81
Fifty two week high 998.33
Fifty two week change 12.284
Beta 0.141
Day 50 ma 951.8694
Day 200 ma 860.1963

Dividends and splits

Recent REGN News